Two-year real-world data from a study involving a patient cohort with a mean lesion length of 12.09 cm showed the use of Medtronic's In.Pact Admiral drug-coated balloon demonstrated an 83.3% rate of freedom from clinically driven target lesion revascularization. Four-year results from a separate study also showed that use of the device led to a longer period of time to reintervention and a higher freedom from CD-TLR rate, compared with percutaneous transluminal angioplasty.
Data show positive results for Medtronic's drug-coated balloon
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.